• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种通过CD4 +辅助性T细胞-抗原呈递细胞产生的CD8 +效应T细胞反应的新动态模型。

A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells.

作者信息

Xiang Jim, Huang Hui, Liu Yongqing

机构信息

Research Unit, Saskatchewan Cancer Agency, Department of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

出版信息

J Immunol. 2005 Jun 15;174(12):7497-505. doi: 10.4049/jimmunol.174.12.7497.

DOI:10.4049/jimmunol.174.12.7497
PMID:15944248
Abstract

A long-standing paradox in cellular immunology has been the conditional requirement for CD4(+) Th cells in priming of CD8(+) CTL responses. We propose a new dynamic model of CD4(+) Th cells in priming of Th-dependent CD8(+) CTL responses. We demonstrate that OT II CD4(+) T cells activated by OVA-pulsed dendritic cells (DC(OVA)) are Th1 phenotype. They acquire the immune synapse-composed MHC II/OVAII peptide complexes and costimulatory molecules (CD54 and CD80) as well as the bystander MHC class I/OVAI peptide complexes from the DC(OVA) by DC(OVA) stimulation and thus also the potential to act themselves as APCs. These CD4(+) Th-APCs stimulate naive OT I CD8(+) T cell proliferation through signal 1 (MHC I/OVAI/TCR) and signal 2 (e.g., CD54/LFA-1 and CD80/CD28) interactions and IL-2 help. In vivo, they stimulate CD8(+) T cell proliferation and differentiation into CTLs and induce effective OVA-specific antitumor immunity. Taken together, this study demonstrates that CD4(+) Th cells carrying acquired DC Ag-presenting machinery can, by themselves, efficiently stimulate CTL responses. These results have substantial implications for research in antitumor and other aspects of immunity.

摘要

细胞免疫学中一个长期存在的悖论是,CD8(+) CTL反应启动对CD4(+) Th细胞有条件需求。我们提出了一个关于Th依赖的CD8(+) CTL反应启动过程中CD4(+) Th细胞的新动态模型。我们证明,被OVA脉冲树突状细胞(DC(OVA))激活的OT II CD4(+) T细胞呈Th1表型。它们通过DC(OVA)刺激从DC(OVA)获得由免疫突触组成的MHC II/OVAII肽复合物、共刺激分子(CD54和CD80)以及旁观者MHC I类/OVAI肽复合物,因此自身也有作为抗原呈递细胞(APC)的潜力。这些CD4(+) Th-APC通过信号1(MHC I/OVAI/TCR)和信号2(如CD54/LFA-1和CD80/CD28)相互作用以及IL-2辅助刺激幼稚OT I CD8(+) T细胞增殖。在体内,它们刺激CD8(+) T细胞增殖并分化为CTL,诱导有效的OVA特异性抗肿瘤免疫。综上所述,本研究表明携带获得性DC抗原呈递机制的CD4(+) Th细胞自身可有效刺激CTL反应。这些结果对肿瘤免疫及其他免疫方面的研究具有重要意义。

相似文献

1
A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells.一种通过CD4 +辅助性T细胞-抗原呈递细胞产生的CD8 +效应T细胞反应的新动态模型。
J Immunol. 2005 Jun 15;174(12):7497-505. doi: 10.4049/jimmunol.174.12.7497.
2
CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses.具有获得性肽/MHC I类和II类复合物的CD4+ Th-抗原呈递细胞刺激1型辅助性CD4+和中枢记忆性CD8+ T细胞反应。
J Immunol. 2009 Jan 1;182(1):193-206. doi: 10.4049/jimmunol.182.1.193.
3
Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.活化的CD4+辅助性T细胞直接刺激野生型和MHC II基因敲除的C57BL/6小鼠以及表达胰岛β细胞卵清蛋白抗原的转基因RIP-mOVA小鼠体内的CD8+细胞毒性T淋巴细胞反应,从而导致糖尿病。
Autoimmunity. 2008 Nov;41(7):501-11. doi: 10.1080/08916930802069256.
4
CD8+ cytotoxic T-APC stimulate central memory CD8+ T cell responses via acquired peptide-MHC class I complexes and CD80 costimulation, and IL-2 secretion.CD8 + 细胞毒性T细胞与抗原呈递细胞(APC)通过获得性肽 - 主要组织相容性复合体I类复合物、CD80共刺激和白细胞介素-2分泌来刺激中枢记忆CD8 + T细胞反应。
J Immunol. 2006 Sep 1;177(5):2976-84. doi: 10.4049/jimmunol.177.5.2976.
5
Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.CD4+调节性T细胞或辅助性细胞递呈获得性肽-MHC II类配体,可不同程度地调节抗原特异性CD4+ T细胞反应。
J Immunol. 2011 Feb 15;186(4):2148-55. doi: 10.4049/jimmunol.1002917. Epub 2011 Jan 17.
6
Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.树突状细胞通过外泌体 LFA-1 募集 T 细胞外泌体,导致肽/MHC Ⅰ类和 Fas 配体介导的细胞毒性下调,从而抑制 CD8+ CTL 应答。
J Immunol. 2010 Nov 1;185(9):5268-78. doi: 10.4049/jimmunol.1000386. Epub 2010 Sep 29.
7
CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes.CD4+ Th1细胞通过经由获得性pMHC I复合物靶向递送白细胞介素2来促进CD8+ Tc1细胞的存活、记忆反应、肿瘤定位及治疗。
Immunology. 2007 Feb;120(2):148-59. doi: 10.1111/j.1365-2567.2006.02452.x.
8
Enhanced suppression of polyclonal CD825 regulatory T cells via exosomal arming of antigen-specific peptide/MHC complexes.通过抗原特异性肽/主要组织相容性复合体的外泌体武装增强对多克隆CD8⁺调节性T细胞的抑制作用。
J Leukoc Biol. 2017 May;101(5):1221-1231. doi: 10.1189/jlb.3A0716-295RR. Epub 2017 Jan 17.
9
Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency.在较高的 CD8(+) T 细胞前体频率下,CD4(+) T 细胞信号对效应细胞毒性 T 淋巴细胞 (CTL) 启动和功能性记忆 CTL 发育的差异需求。
Immunology. 2013 Apr;138(4):298-306. doi: 10.1111/imm.12033.
10
Acquired pMHC I complexes greatly enhance CD4(+) Th cell's stimulatory effect on CD8(+) T cell-mediated diabetes in transgenic RIP-mOVA mice.在转基因RIP-mOVA小鼠中,获得性pMHC I复合物极大地增强了CD4(+) Th细胞对CD8(+) T细胞介导的糖尿病的刺激作用。
Cell Mol Immunol. 2008 Dec;5(6):407-15. doi: 10.1038/cmi.2008.51.

引用本文的文献

1
Secretory exosomes from modified immune cells against cancer.源自经修饰的抗癌免疫细胞的分泌性外泌体。
Med Oncol. 2025 Apr 10;42(5):159. doi: 10.1007/s12032-025-02706-4.
2
The Biological Significance of Trogocytosis.细胞融合的生物学意义
Results Probl Cell Differ. 2024;73:87-129. doi: 10.1007/978-3-031-62036-2_5.
3
Outsmarting trogocytosis to boost CAR NK/T cell therapy.智取 trogocytosis 以增强 CAR NK/T 细胞疗法。
Mol Cancer. 2023 Nov 16;22(1):183. doi: 10.1186/s12943-023-01894-9.
4
Physiological and therapeutic relevance of T cell receptor-mediated antigen trogocytosis.T 细胞受体介导的抗原 trogocytosis 的生理和治疗相关性。
Biomed J. 2024 Oct;47(5):100630. doi: 10.1016/j.bj.2023.100630. Epub 2023 Jul 15.
5
CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis.CTLA4 通过顺式内吞作用耗竭 T 细胞内源性和转胞吞作用的 B7 配体。
J Exp Med. 2023 Jul 3;220(7). doi: 10.1084/jem.20221391. Epub 2023 Apr 12.
6
Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice.预先免疫细胞内抗原可增强小鼠随后的红细胞同种免疫。
Blood. 2023 May 25;141(21):2642-2653. doi: 10.1182/blood.2022016588.
7
A novel costimulatory molecule gene-modified leukemia cell-derived exosome-targeted CD4 T cell vaccine efficiently enhances anti-leukemia immunity.一种新型共刺激分子基因修饰的白血病细胞衍生外泌体靶向 CD4 T 细胞疫苗可有效增强抗白血病免疫。
Front Immunol. 2022 Nov 16;13:1043484. doi: 10.3389/fimmu.2022.1043484. eCollection 2022.
8
Differential trafficking of ligands trogocytosed via CD28 versus CTLA4 promotes collective cellular control of co-stimulation.配体通过 CD28 与 CTLA4 内化后的差异转运促进共刺激的细胞集体控制。
Nat Commun. 2022 Oct 29;13(1):6459. doi: 10.1038/s41467-022-34156-1.
9
Gnawing Between Cells and Cells in the Immune System: Friend or Foe? A Review of Trogocytosis.免疫细胞间的吞噬作用:敌是友?对细胞吞噬作用的综述
Front Immunol. 2022 Feb 3;13:791006. doi: 10.3389/fimmu.2022.791006. eCollection 2022.
10
Lymphocytes and Trogocytosis-Mediated Signaling.淋巴细胞与细胞吞噬作用介导的信号转导。
Cells. 2021 Jun 12;10(6):1478. doi: 10.3390/cells10061478.